| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hyun Jun Lee, Darlene Mae Ortiz, Leandro Val Sayson, Mikyung Kim, Jae Hoon Cheong, Hee Jin Ki. Ameliorating effects of Acanthopanax koreanum extract and components on nicotine dependence and withdrawal symptoms. Addiction biology. vol 29. issue 2. 2024-02-21. PMID:38380695. |
furthermore, it normalized the dopamine concentration and the expression level of nicotine acetylcholine receptor α7. |
2024-02-21 |
2024-02-23 |
mouse |
| Ashwini Wani, Bala Prabhakar, Pravin Shend. Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2023-12-30. PMID:38159871. |
nicotine released in a sustained manner attaches to the nicotine acetylcholine receptors (nachr) to release dopamine for controlling the withdrawal challenges such as anxiety, irritability, cravings, disturbed sleep pattern, etc. |
2023-12-30 |
2024-01-05 |
Not clear |
| Ashwini Wani, Bala Prabhakar, Pravin Shend. Competitive inhibition of nicotine acetylcholine receptors using microneedles of nicotine and varenicline for smoking withdrawal therapy. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2023-12-30. PMID:38159871. |
the varenicline released from microneedles binds to the nachr and inhibits dopamine release responsible for the euphoric effect induced by nicotine, and thus assists in curbing the nicotine withdrawal symptoms. |
2023-12-30 |
2024-01-05 |
Not clear |
| Sarabesh Natarajan, Grant Abass, Lucas Kim, Corinne Wells, Amir H Rezvani, Edward D Levi. Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D Pharmacology, biochemistry, and behavior. 2023-11-18. PMID:37979731. |
acute and chronic glutamate nmda antagonist treatment attenuates dopamine d multiple interacting neural systems are involved in sustaining nicotine reinforcement. |
2023-11-18 |
2023-11-20 |
Not clear |
| Ruvini Amarasekera, Evan Woo. Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect? BMJ case reports. vol 16. issue 10. 2023-10-31. PMID:37907321. |
while dopamine antagonists are recognised to stimulate food craving and weight gain, outside of possibly increasing nicotine craving and use, their impact on other sud outcomes is poorly recognised. |
2023-10-31 |
2023-11-08 |
Not clear |
| Xiaonan Li, Lehua Lu, Ying He, Hui Zhang, Yihui Zhang, Huaquan Sheng, Ming Chen, Jiexiong Ru, Yihan Ga. Pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens. Frontiers in pharmacology. vol 14. 2023-10-16. PMID:37841907. |
pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens. |
2023-10-16 |
2023-11-08 |
mouse |
| Xiaonan Li, Lehua Lu, Ying He, Hui Zhang, Yihui Zhang, Huaquan Sheng, Ming Chen, Jiexiong Ru, Yihan Ga. Pharmacological effects of nicotine salts on dopamine release in the nucleus accumbens. Frontiers in pharmacology. vol 14. 2023-10-16. PMID:37841907. |
nicotine increases the release of dopamine (da) into the nucleus accumbens (nac), causing feelings of satisfaction. |
2023-10-16 |
2023-11-08 |
mouse |
| Kristen Kim, Marina R Picciott. Nicotine addiction: More than just dopamine. Current opinion in neurobiology. vol 83. 2023-10-13. PMID:37832393. |
nicotine addiction: more than just dopamine. |
2023-10-13 |
2023-10-15 |
Not clear |
| Jázmin Ayman, Miklós Palotai, Roberta Dochnal, Zsolt Bagos. Ghrelin Amplifies the Nicotine-Induced Release of Dopamine in the Bed Nucleus of Stria Terminalis (BNST). Biomedicines. vol 11. issue 9. 2023-09-28. PMID:37760897. |
in our previous in vitro superfusion studies, it was demonstrated that ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala, and ghrelin amplifies the nicotine-induced dopamine release in the rat striatum. |
2023-09-28 |
2023-10-07 |
rat |
| Jázmin Ayman, Miklós Palotai, Roberta Dochnal, Zsolt Bagos. Ghrelin Amplifies the Nicotine-Induced Release of Dopamine in the Bed Nucleus of Stria Terminalis (BNST). Biomedicines. vol 11. issue 9. 2023-09-28. PMID:37760897. |
therefore, in the present study, nicotine and ghrelin were superfused to the bnst of male wistar rats, and the dopamine release from the bnst was measured in vitro. |
2023-09-28 |
2023-10-07 |
rat |
| Jázmin Ayman, Miklós Palotai, Roberta Dochnal, Zsolt Bagos. Ghrelin Amplifies the Nicotine-Induced Release of Dopamine in the Bed Nucleus of Stria Terminalis (BNST). Biomedicines. vol 11. issue 9. 2023-09-28. PMID:37760897. |
nicotine significantly increased the release of dopamine, and this effect was significantly inhibited by mecamylamine. |
2023-09-28 |
2023-10-07 |
rat |
| Jázmin Ayman, Miklós Palotai, Roberta Dochnal, Zsolt Bagos. Ghrelin Amplifies the Nicotine-Induced Release of Dopamine in the Bed Nucleus of Stria Terminalis (BNST). Biomedicines. vol 11. issue 9. 2023-09-28. PMID:37760897. |
ghrelin increased dopamine release even more significantly than nicotine did, and this effect was significantly inhibited by ghrp-6. |
2023-09-28 |
2023-10-07 |
rat |
| Jázmin Ayman, Miklós Palotai, Roberta Dochnal, Zsolt Bagos. Ghrelin Amplifies the Nicotine-Induced Release of Dopamine in the Bed Nucleus of Stria Terminalis (BNST). Biomedicines. vol 11. issue 9. 2023-09-28. PMID:37760897. |
therefore, the present study provides a new base of evidence for the involvement of ghrelin in dopamine signaling implicated in nicotine addiction. |
2023-09-28 |
2023-10-07 |
rat |
| Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzee. Dopamine D1-like receptor activation decreases nicotine intake in rats with short or long access to nicotine. Addiction biology. vol 28. issue 8. 2023-07-27. PMID:37500487. |
dopamine d1-like receptor activation decreases nicotine intake in rats with short or long access to nicotine. |
2023-07-27 |
2023-08-14 |
human |
| Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzee. Dopamine D1-like receptor activation decreases nicotine intake in rats with short or long access to nicotine. Addiction biology. vol 28. issue 8. 2023-07-27. PMID:37500487. |
dopamine d1-like receptor blockade diminishes nicotine intake in rats with daily short (1 h) access to nicotine, but little is known about the effects of dopamine receptor antagonists or agonists on nicotine intake in rats with intermittent long (23 h) access. |
2023-07-27 |
2023-08-14 |
human |
| Ranjithkumar Chellian, Azin Behnood-Rod, Ryann Wilson, Karen Lin, Grace Wing-Yan King, Adriaan W Bruijnzee. Dopamine D1-like receptor activation decreases nicotine intake in rats with short or long access to nicotine. Addiction biology. vol 28. issue 8. 2023-07-27. PMID:37500487. |
we investigated the effects of the dopamine d1-like receptor antagonist sch 23390 and the d1-like receptor agonist a77636 on nicotine intake in male rats with intermittent short or long access to nicotine. |
2023-07-27 |
2023-08-14 |
human |
| Laramie Duncan, Karl Deisserot. Are novel treatments for brain disorders hiding in plain sight? Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2023-07-08. PMID:37422511. |
we focus on schizophrenia and the dopamine d2 receptor (drd2), hot flashes and the neurokinin b receptor (tacr3), cigarette smoking and receptors bound by nicotine (chrna5, chrna3, chrnb4), and alcohol use and enzymes that help to break down alcohol (adh1b, adh1c, adh7). |
2023-07-08 |
2023-08-14 |
human |
| Yasmin Zakiniaeiz, Ralitza Gueorguieva, MacKenzie R Peltier, Terril L Verplaetse, Walter Roberts, Sherry A McKee, Kelly P Cosgrov. Sex steroid hormone levels associated with dopamine D Frontiers in behavioral neuroscience. vol 17. 2023-06-27. PMID:37358969. |
nicotine binds to nicotinic acetylcholine receptors, facilitating dopamine release in striatal and cortical brain regions. |
2023-06-27 |
2023-08-14 |
Not clear |
| Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman, Nicola Lindso. Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews. vol 5. 2023-05-04. PMID:37142273. |
nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). |
2023-05-04 |
2023-08-14 |
Not clear |
| Kechun Yang, Ian McLaughlin, Jessica K Shaw, Natalia Quijano-Cardé, John A Dani, Mariella De Bias. CHRNA5 gene variation affects the response of VTA dopaminergic neurons during chronic nicotine exposure and withdrawal. Neuropharmacology. 2023-04-28. PMID:37116611. |
in rodents, α5-containing nachrs in dopamine (da) neurons within the ventral tegmental area (vta) powerfully modulate nicotine reward and reinforcement. |
2023-04-28 |
2023-08-14 |
mouse |